Clinical Implications of Pharmacokinetic Changes in Pregnancy: A Systematic Review

Pregnancy induces significant physiological changes that can alter the pharmacokinetics of drugs, influencing their absorption, distribution, metabolism, and elimination. These changes are critical for ensuring the safety and efficacy of pharmacotherapy in pregnant women, but they also pose challenges in optimizing drug dosing. This systematic review aims to provide a comprehensive overview of the pharmacokinetic changes that occur during pregnancy and their clinical implications. We examine the alterations in gastrointestinal absorption, renal clearance, hepatic metabolism, and plasma protein binding that can affect drug levels and therapeutic outcomes. Special attention is given to the role of hormonal changes, increased blood volume, and renal function alterations in modifying drug pharmacokinetics. The review discusses how these physiological adaptations can lead to altered drug concentrations, which may increase the risk of adverse effects or reduce the therapeutic efficacy of medications. We also evaluate how specific drugs are affected by these pharmacokinetic changes, with examples from commonly prescribed medications for managing conditions such as hypertension, diabetes, and infections. Furthermore, we assess the impact of pregnancy-related pharmacokinetic changes on drug safety and efficacy for both the mother and the fetus, emphasizing the need for personalized dosing strategies. Finally, we address the gaps in research regarding the pharmacokinetics of drugs during pregnancy, especially for those medications used in specialized care, and propose future directions for research in this area. Ultimately, understanding pharmacokinetic changes during pregnancy is essential for optimizing drug therapy and minimizing risks to both maternal and fetal health.